Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 13, 2006 - Issue 3
123
Views
4
CrossRef citations to date
0
Altmetric
CaseReport

Systemic AA-amyloidosis related to MPO-ANCA microscopic polyangiitis: A case report

, , , , , , , , , , , , & show all
Pages 178-183 | Published online: 06 Jul 2009
 

Abstract

We report autopsy findings in an 83-year-old woman with myeloperoxidase-type anti-neutrophil cytoplasmic antibody (MPO-ANCA)-positive microscopic polyangiitis and systemic AA amyloidosis. With a diagnosis of MPO-ANCA-related microscopic polyangiitis, the patient was treated with corticosteroids, but she died of intractable enteritis. Autopsy showed inactive vasculitis affecting small arteries in kidney, lung, intestinal tract, and skeletal muscle. Gastrointestinal viscera were thickened, and AA-amyloid was demonstrated in arterioles and surrounding tissues. Amyloidosis also involved heart, kidney, gallbladder, pancreas, salivary gland, and subcutis. ANCA-positive microscopic polyangiitis appears to have been the likely cause of this patient's AA-amyloidosis.

Abbreviations
MPO-ANCA=

myeloperoxidase-type anti-neutrophil cytoplasmic antibody

FMA=

familial Mediterranean fever

MPA=

microscopic polyangiitis

Abbreviations
MPO-ANCA=

myeloperoxidase-type anti-neutrophil cytoplasmic antibody

FMA=

familial Mediterranean fever

MPA=

microscopic polyangiitis

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.